Medroxyprogesterone Acetate Injectable Suspension Injection, Suspension
Product Images NDC 24201-150

4 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate Injectable Suspension (NDC 24201-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Medroxyprogesterone Acetate Injectable Suspension 1)

Figure 1 (Medroxyprogesterone Acetate Injectable Suspension 1)
A forest plot chart depicting odds ratios with 95% confidence intervals for various studies and subject groups assessing risk related to DMPA (medroxyprogesterone acetate). The odds ratios are displayed on a logarithmic scale, with values ranging approximately from 0.6 to 7.4, comparing several studies from 1987 to 2012.*
FDA Label Image

Chemical Structure (Medroxyprogesterone Acetate Injectable Suspension 2)

Chemical Structure (Medroxyprogesterone Acetate Injectable Suspension 2)
Chemical structure of medroxyprogesterone acetate, shown as a detailed molecular diagram with labeled atoms and bond configurations.*
FDA Label Image

Figure 2 (Medroxyprogesterone Acetate Injectable Suspension 3)

Figure 2 (Medroxyprogesterone Acetate Injectable Suspension 3)
An illustration showing a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom, with pregnancy rates per 100 women in one year on the left. It categorizes birth control methods by effectiveness: implants, injections, intrauterine devices, and sterilization at the top; birth control pills, skin patches, and vaginal rings with hormones next; condoms and diaphragm in the middle; no sex during fertile days, spermicide, and withdrawal below that; and no birth control at the bottom.*
FDA Label Image

Vial Label (Medroxyprogesterone Acetate Injectable Suspension 4)

Vial Label (Medroxyprogesterone Acetate Injectable Suspension 4)
Label for Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg/mL, for intramuscular use only. The product is packaged as a 1 mL single-dose vial. Label includes directions to see prescribing information and to shake vigorously before use. Manufactured for Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.